An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

Thies Rösner; Stefanie Derer; Christian Kellner; Michael Dechant; Stefan Lohse; Gestur Vidarsson; Matthias Peipp; Thomas Valerius

doi:10.1111/bjh.12209

An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

Thies Rösner, Stefanie Derer^*, Christian Kellner, Michael Dechant, Stefan Lohse, Gestur Vidarsson, Matthias Peipp, Thomas Valerius

^*Corresponding author for this work

Institute of Nutritional Medicine

24 Citations (Scopus)

Original language	English
Journal	British Journal of Haematology
Volume	161
Issue number	2
Pages (from-to)	282-286
Number of pages	5
ISSN	0007-1048
DOIs	https://doi.org/10.1111/bjh.12209
Publication status	Published - 04.2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Access to Document

10.1111/bjh.12209

Cite this

@article{002dfcfaaa534426887fb7a9d9d9af60,

title = "An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels",

author = "Thies R{\"o}sner and Stefanie Derer and Christian Kellner and Michael Dechant and Stefan Lohse and Gestur Vidarsson and Matthias Peipp and Thomas Valerius",

year = "2013",

month = apr,

doi = "10.1111/bjh.12209",

language = "English",

volume = "161",

pages = "282--286",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc",

number = "2",

}

TY - JOUR

T1 - An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

AU - Rösner, Thies

AU - Derer, Stefanie

AU - Kellner, Christian

AU - Dechant, Michael

AU - Lohse, Stefan

AU - Vidarsson, Gestur

AU - Peipp, Matthias

AU - Valerius, Thomas

PY - 2013/4

Y1 - 2013/4

UR - https://www.scopus.com/pages/publications/84875805834

U2 - 10.1111/bjh.12209

DO - 10.1111/bjh.12209

M3 - Letters

C2 - 23294176

AN - SCOPUS:84875805834

SN - 0007-1048

VL - 161

SP - 282

EP - 286

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -

An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Cite this